Please login to the form below

Not currently logged in
Email:
Password:

Agios Pharma

This page shows the latest Agios Pharma news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs dominate FDA's record-breaking year

Orphan drugs dominate FDA's record-breaking year

drugs, driven on by new pharma and biotech science, and the FDA's determination to accelerate its review times. ... There were also a number of drugs with brand new mechanisms of action, including three CGRP inhibitors for migraine prevention from Amgen,

Latest news

  • Celgene, Agios get FDA OK for leukaemia drug Idhifa Celgene, Agios get FDA OK for leukaemia drug Idhifa

    Duo’s drug becomes first new AML therapy since Novartis' Rydapt. Celgene and Agios Pharma have claimed FDA approval for Idhifa, a new drug that is targeted at patients with a ... That kicked off in 2010 with a $130m upfront payment from Celgene to Agios

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Agios appoints Celgene’s Jackie Fouse Agios appoints Celgene’s Jackie Fouse

    She joins the pharma group’s board of directors. Cancer and rare genetic disease focused group Agios Pharmaceuticals has appointed Jackie Fouse to its board of directors as the company prepares ... growing biotechnology company, so we are thrilled to

  • Chris Bowden joins Agios Chris Bowden joins Agios

    He is former VP, product development oncology at Genentech. Agios Pharma has named former Genentech VP Chris Bowden as chief medical officer. ... Bowden's knowledge of oncology will benefit Agios as it prepares to advance the development of three

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics